Verbal memory test best indicator of who will have Alzheimer’s disease, new study says
Early Detection of Alzheimers Could Lessen the Impact
Incidence of Alzheimers Disease is expected to increase as the population of elderly grows. Early diagnosis and treatment will be the key to lessening the diseases worst effects, but, how to spot the disease before its symptoms become serious (and harm is already done) is a challenge for health professionals. A new study by psychologists Konstantine K. Zakzanis, Ph.D., and Mark Boulos, B.Sc., of the University of Toronto has determined that the best predictor of future Alzheimers type dementia is a verbal memory test. Their study will be presented in Chicago at the 110th Annual Convention of the American Psychological Association (APA).
In a meta-analysis of 31 studies amounting to 1,144 Alzheimers patients and 6,046 healthy controls, Zakzanis and Boulos looked at both neuropsychological and neuroimaging tests to determine their ability to detect preclinical dementia and/or Alzheimers disease. They also paired a genetic susceptibility (presence of the ApoE gene) to dementia/Alzheimers with results on both neuropsychological and neuroanatomic tests again attempting to identify which types of tests would prove most accurate in identifying preclinical disease in patients with the ApoE gene.
Specifically, their findings support the use of the California Verbal Learning Test (long delay recall and percent recall) as the best predictor of Alzheimers type dementia, with executive function type measures also being predictive but less so than both the long and short delay memory tests.
Changes in the hippocampus were the best volumetric or neuroimaging measure but in general volumetric measures were less sensitive to preclinical stages of the dementia than were the neuropsychological tests.
Ironically, while memory assessments were also more predictive of preclinical Alzheimers than neuroimaging tests for people with the ApoE gene, the most predictive test for such persons still appears to be an odor identification test.
In presenting their findings, the authors note that decline in memory, especially in verbal episodic memory, can be observed in normal elderly people as well as in elderly with mild cognitive impairments and that most of those people will not become future victims of Alzheimers. How can we tell the difference between those elderly with normal memory impairments and those with preclinical Alzheimers? The answer, according to the researchers, lies in the magnitude of the memory deficit. Because their study was a meta-analysis of effect sizes, the results allowed them to compare the size of the difference between normal older adults with normal memory decline and older adults with actual dementia.
Presentation: “A Meta-Analysis of ApoE Genotype and Neuropsychologic and Neuroanatomic Changes in Preclinical Alzheimers Disease,” Konstantine K. Zakzanis, Ph.D., University of Toronto, and Mark I. Boulos, B.Sc., University of Toronto, Session 4140, 10:00 – 11:50 AM, August 25, 2002, McCormick Place, Lakeside Center-Level 4, Meeting Room E451a.
Alle Nachrichten aus der Kategorie: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Scientists solve big limitation of stratospheric balloon payloads
How do you cool a large telescope to absolute zero while flying it from a huge balloon at 130,000 feet? Nearly all photons emitted after the Big Bang are now…
Ultrasensitive transistor for herbicide detection in water
A new polymer-based, solid-state transistor can more sensitively detect a weed killer in drinking water than existing hydrogel-based fluorescence sensor chips. The details were published in Chemistry-A European Journal. The…